HOME
ABOUT US
CLINICAL CAPABILITIES 
PRINCIPAL INVESTIGATORS 
CURRENT STUDIES
VOLUNTEER
OUR LOCATION 
CONTACT US 

J. Christopher Stringer, M.D., CPI
Curriculum Vitae
 

Education:

  • Graduate: Syracuse University
    1970-1971, MS

  • Post Graduate: State University of New York
    Syracuse, New York
    1972-1976, MD
     

Internship:

  • Pennsylvania State University at Hershey Medical Center, Hershey, Pennsylvania
    1976-1977
     

Residency:

  • State University of New York Health Science Center
    Syracuse, New York
    1977-1980
     

License:

  • State of New York (License #141135-1)
    1980 - Present
     

Certifications:

  • American Board of Internal Medicine
    1980

  • Recertification
    1992

  • ACRP CCRI certification 2002
     

Professional Experience:

  • Principal Investigator/Medical Director
    Central New York Clinical Research
    Manlius, New York
    1992 - Present 

  • Private Practice Physician
    CNY Internists
    Manlius, New York
    1980 - Present
     

Research Grants:

  • Constipation (Sucampo)

  • Diabetes (Astra Zeneca)

  • Skin Infection (GSK)

  • Diabetes/Hypertension (Pfizer)

  • Obesity (Sanofi Synthelabo)

  • Migraine (Pfizer)

  • Migraine - Vioxx (Merck)

  • Hyperlipidemia (Merck)

  • Pravachol-Lipids (Bristol-Myers Squibb)

  • Irritable Bowel Syndrome (TAP)

  • Alosetron-Irritable Bowel Syndrome (Glaxo Wellcome)

  • Hypertension (Searle)

  • Lorabid-Sinusitis (Lilly)

  • Naratriptan-Migraines (Glaxo Wellcome)

  • Celebrex-OA/RA (Searle) - Four studies

  • Influenza (Hoffman LaRoche) - Two studies

  • Hypertension (Bristol-Myers Squibb) - multiple studies

  • Community Acquired Pneumonia (Abbott)

  • Osteoarthritis (Merck) -multiple studies

  • Eletriptan-Migraines (Pfizer) - multiple studies

  • Hypertension (Sankyo)

  • Community Acquired Pneumonia (Tap)

  • Flonase-Sinusitis (Glaxo Wellcome)

  • Avapro-Hypertension (Bristol-Myers Squibb)

  • Cozaar-Merck LIFE Study

  • Cozaar-Hypertension (Merck)

  • Augmentin-Sinusitis/Pneumonia (SmithKline Beechman)

  • Ceftin-Sinusitis (Glaxo)

  • Beraprost-Claudication (Hoescht Marion Roussel)

  • Hormone Replacement Therapy (Rhone Poulenc Rorer)

  • Diovan-Hypertension (Ciba-Geigy) - Two studies

  • Dexiprofen-Osteoarthritis (Sterling Winthrop)

  • Famcyclovir-Herpes Zoster (SmithKline Beecham)

  • Voltaren-Osteoarthritis (Ciba Geigy)

 

Rev. 11/01


Central New York Clinical Research
Route 92 - The Market Place - Manlius, New York 13104
(315) 682-3263  -  Fax: 682-2030
Emai
l: info@cnycr.com